FYI ...

60%

Percentage of patients with psoriasis who miss an average of 26 days of work per year due to their illness

Source: National Psoriasis Foundation

Connect to Us

Digital Edition

Zelboraf approved for melanoma

Washington — The Food and Drug Administration (FDA) has approved the oral targeted therapy vemurafenib (Zelboraf, Plexxikon/Roche) for treatment of metastatic and unresectable melanomas, Medscape Today reports. Read full article.

Confirm your e-newsletter subscription click here.

To ensure future delivery of email newsletters from
Dermatology Times please take a moment to confirm your subscription by clicking here.
Thank you,
Dermatology Times Staff

Children's MRSA infections rise

Sacramento, Calif. — The number of children hospitalized for skin and soft-tissue infections, mainly due to community-acquired methicillin-resistant Staphylococcus aureus (MRSA), has more than doubled over the past decade, Medical News Today reports. Read full article.

Pressure device treats ear keloids

Mannheim, Germany — Results of a small study suggest that there is significant potential for a pressure device used to supplement other treatments for auricular keloids, Medical News Today reports. Read full article.

Most doctors will be sued by age 65

Cambridge, Mass. — Most doctors will face at least one malpractice lawsuit by age 65, according to a new study. But dermatologists are among the least-sued specialists, Medscape Today reports. Read full article.

Career Opportunities

All Island Dermatology	Arizona Skin & Laser
Arizona Skin & Laser	Cynthia Dreyer MD
Dr. Ira Schlesinger	David Geffen School of Medicine at UCLA
David A High MD	Mark Burnett MD
Metropolitan Dermatology	Ochsner Health System
Plastic Surgery of Southern CT	Richard G Glogau
Westlake Dermatology

Contact Us

Contact a Dermatology Times editor Click Here
Contact a Dermatology Times sales representative Click Here
Learn about direct mail, reprints and classifieds in Dermatology Times Click Here

You are subscribed to %%list.name%% as %%emailaddr%%. Click here to unsubscribe or edit your member profile.

To ensure delivery to your inbox, please add us to your address book. If you need help doing this, Click here.

Advanstar Communications provides certain customer contact data (such as customers' names, addresses, phone numbers and e-mail addresses) to third parties who wish to promote relevant products, services and other opportunities which may be of interest to you. If you do not want Advanstar Communications to make your contact information available to third parties for marketing purposes, simply call (toll free) 866-529-2922 at any time, or
fax us at 218-740-6417. Outside the U.S., please phone 218-740-6395. Contact us by mail at Advanstar Communications Inc., 131 West First St., Duluth, MN 55802-2065, USA.